Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?

Though, Conjunctivo-limbal auto-graft is the most accepted adjuvant to prevent recurrence of pterygium, has its own limitations like difficulty to cover large defect and to preserve for future glaucoma surgeries, necessiating to find an alternative especially, in young patients. The outcomes between...

Full description

Bibliographic Details
Main Author: P Shashikala
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Clinical Ophthalmology and Research
Online Access:http://www.jcor.in/article.asp?issn=2320-3897;year=2013;volume=1;issue=2;spage=91;epage=93;aulast=Shashikala
id doaj-12273d8bd489442d9bd57e27724d5c2c
record_format Article
spelling doaj-12273d8bd489442d9bd57e27724d5c2c2020-11-25T00:26:00ZengWolters Kluwer Medknow PublicationsJournal of Clinical Ophthalmology and Research2320-38972013-01-0112919310.4103/2320-3897.112177Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?P ShashikalaThough, Conjunctivo-limbal auto-graft is the most accepted adjuvant to prevent recurrence of pterygium, has its own limitations like difficulty to cover large defect and to preserve for future glaucoma surgeries, necessiating to find an alternative especially, in young patients. The outcomes between amniotic membrane transplantation (AMT) and conjunctivo-limbal auto graft transplantation (CLAT) as an adjuvant following excision of primary pterygia from Jan. 2010 to Dec.2010 were compared. Twenty four patients had AMT and 28 patients had CLAT after pterygium excision and followed for minimum of 12 months; evaluated in terms of recurrence or complications. We had 44% young (<40yrs) with 58% female. Epithelial healing occurred within a week. AMT cases showed 8% recurrence, nil in CLAT but, with 2 cases of pyogenic granuloma. We conclude that, AMT as an adjuvant would be a viable option reserving CLAT for those with recurrence or as a last resort especially, in younger patients.http://www.jcor.in/article.asp?issn=2320-3897;year=2013;volume=1;issue=2;spage=91;epage=93;aulast=Shashikala
collection DOAJ
language English
format Article
sources DOAJ
author P Shashikala
spellingShingle P Shashikala
Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?
Journal of Clinical Ophthalmology and Research
author_facet P Shashikala
author_sort P Shashikala
title Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?
title_short Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?
title_full Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?
title_fullStr Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?
title_full_unstemmed Is amniotic membrane transplantation, an adjuvant of choice following excision of primary Pterygium?
title_sort is amniotic membrane transplantation, an adjuvant of choice following excision of primary pterygium?
publisher Wolters Kluwer Medknow Publications
series Journal of Clinical Ophthalmology and Research
issn 2320-3897
publishDate 2013-01-01
description Though, Conjunctivo-limbal auto-graft is the most accepted adjuvant to prevent recurrence of pterygium, has its own limitations like difficulty to cover large defect and to preserve for future glaucoma surgeries, necessiating to find an alternative especially, in young patients. The outcomes between amniotic membrane transplantation (AMT) and conjunctivo-limbal auto graft transplantation (CLAT) as an adjuvant following excision of primary pterygia from Jan. 2010 to Dec.2010 were compared. Twenty four patients had AMT and 28 patients had CLAT after pterygium excision and followed for minimum of 12 months; evaluated in terms of recurrence or complications. We had 44% young (<40yrs) with 58% female. Epithelial healing occurred within a week. AMT cases showed 8% recurrence, nil in CLAT but, with 2 cases of pyogenic granuloma. We conclude that, AMT as an adjuvant would be a viable option reserving CLAT for those with recurrence or as a last resort especially, in younger patients.
url http://www.jcor.in/article.asp?issn=2320-3897;year=2013;volume=1;issue=2;spage=91;epage=93;aulast=Shashikala
work_keys_str_mv AT pshashikala isamnioticmembranetransplantationanadjuvantofchoicefollowingexcisionofprimarypterygium
_version_ 1725346490827669504